Ticker > Company >

Krsnaa Diagnostics share price

Krsnaa Diagnostics Ltd.

NSE: KRSNAA BSE: 543328 SECTOR: Hospital & Healthcare Services  1.41 L   240   60

587.65
-7.45 (-1.25%)
NSE: 20 Mar 4:00 PM

Price Summary

Today's High

₹ 602.95

Today's Low

₹ 586

52 Week High

₹ 894.4

52 Week Low

₹ 579.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1906.26 Cr.

Enterprise Value

2039.97 Cr.

No. of Shares

3.24 Cr.

P/E

23.72

P/B

2.01

Face Value

₹ 5

Div. Yield

0.47 %

Book Value (TTM)

₹  292.33

CASH

67.91 Cr.

DEBT

201.62 Cr.

Promoter Holding

27.11 %

EPS (TTM)

₹  24.77

Sales Growth

15.54%

ROE

9.74 %

ROCE

12.96%

Profit Growth

41.4 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.54%
3 Year14.44%
5 Year21.41%

Profit Growth

1 Year41.4%
3 Year5.41%
5 Year22.33%

ROE%

1 Year9.74%
3 Year8.73%
5 Year9.44%

ROCE %

1 Year12.96%
3 Year11.68%
5 Year36.45%

Debt/Equity

0.2273

Price to Cash Flow

21.33

Interest Cover Ratio

5.4615

CFO/PAT (5 Yr. Avg.)

0.948135875147391

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 27.11 0.00
Sep 2025 27.11 0.00
Jun 2025 27.11 0.00
Mar 2025 27.24 0.00
Dec 2024 27.24 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company has been maintaining an effective average operating margins of 26.7267477247799% in the last 5 years.
  • Company’s PEG ratio is 0.572967567521514.
  • The company has an efficient Cash Conversion Cycle of -44.9923 days.

 Limitations

  • The company has shown a poor profit growth of 5.40911116650953% for the Past 3 years.
  • The company has shown a poor revenue growth of 14.4354690441816% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 165.16 174.65 175.62 182.88 159.43
Total Expenditure 117.26 121.35 125.52 124.88 111.76
Operating Profit 47.89 53.31 50.1 58.01 47.68
Other Income 9.29 4.46 4 4.21 3.8
Interest 6.13 6.75 6.25 8.12 7.72
Depreciation 22.69 21.8 21.51 23.47 22.53
Exceptional Items 0 0 0 0 0
Profit Before Tax 28.37 29.21 26.34 30.63 21.22
Tax 6.77 8.15 6.78 7.39 4.73
Profit After Tax 21.6 21.07 19.56 23.24 16.49
Adjusted EPS (Rs) 6.69 6.52 6.03 7.16 5.08

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 396.46 454.89 464.08 590.02 681.7
Total Expenditure 302.65 320.34 339.84 443.86 485.04
Operating Profit 93.81 134.55 124.25 146.16 196.66
Other Income 265.02 14.93 19.41 16.8 25.67
Interest 25.94 18.49 7.68 16.47 24.57
Depreciation 37.44 41.39 53.78 74.55 88.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 295.45 89.6 82.19 71.95 109.6
Tax 110.52 18.9 18.68 13.38 26.79
Net Profit 184.93 70.7 63.51 58.56 82.81
Adjusted EPS (Rs.) 142.36 22.52 20.23 18.14 25.65

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 248.89 15.7 15.7 16.15 16.15
Total Reserves -17.02 671.05 726.8 799.1 877.15
Borrowings 167.95 33.07 24.28 41.88 45.48
Other N/C liabilities 20.91 37.59 47.35 38.39 45.31
Current liabilities 188.55 119.64 95.25 276.05 299.23
Total Liabilities 609.28 877.06 909.38 1171.57 1283.31
Assets
Net Block 308.51 385.69 470.68 647.16 667.68
Capital WIP 3.72 28.26 25.48 9.85 2.96
Intangible WIP 0 0 0 0 0
Investments 0.29 0.36 0.36 0.36 31.62
Loans & Advances 33.83 17.87 26.37 62.37 48.3
Other N/C Assets 10.04 109.11 162.75 29.43 113.59
Current Assets 252.89 335.77 223.75 422.41 419.16
Total Assets 609.28 877.06 909.38 1171.57 1283.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 295.45 89.6 82.19 71.95 109.6
Adjustment -198.74 49.2 44.79 69.9 97.63
Changes in Assets & Liabilities 29.62 -3.46 -38.37 -98.65 -98.16
Tax Paid -7.67 -6.63 -13.13 -18.8 -19.69
Operating Cash Flow 118.66 128.71 75.48 24.39 89.38
Investing Cash Flow -67.37 -241.1 -108.54 -128.88 -101.83
Financing Cash Flow 20.03 176.04 -33.13 84.21 13.91
Net Cash Flow 71.32 63.65 -66.19 -20.27 1.46

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
promoters 27.24 27.24 27.11 27.11 27.11
krsna diagnostics (mumbai... 2.37 2.37 2.36 2.36 2.36
rajendra khivraj mutha 24.87 24.87 24.75 24.75 24.75
PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
investors 72.76 72.76 72.89 72.89 72.89
bandhan small cap fund - - - 1.72 1.79
hdfc life insurance compa... 2.06 2.06 2.05 2.05 2.05
k india opportunities fun... 2.19 2.19 2.18 2.18 1.79
kirankumar prabhakar bhis... 1.23 1.10 1.10 1.10 1.06
medimaze solutions privat... - - - 1.03 1.03
phi capital trust - phi c... 15.44 15.44 15.37 15.37 15.37
tata mutual fund - tata s... 7.73 7.73 7.69 7.97 7.93
bandhan bse healthcare in... 1.25 1.32 1.63 - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY22
Concall Q2FY22
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY26
Presentation Q2FY24
Presentation Q2FY22

Company News

Krsnaa Diagnostics submits newspaper advertisement 17 Mar, 9:16 AM Krsnaa Diagnostics submits notice of postal ballot 16 Mar, 2:25 PM Krsnaa Diagnostics informs about analyst meet 26 Feb, 12:30 PM Krsnaa Diagnostics raises Rs 430 crore via NCDs 23 Feb, 5:00 PM Krsnaa Diagnostics informs about newspaper advertisement 7 Feb, 9:52 AM Krsnaa Diagnostics informs about analyst meet outcome 6 Feb, 4:56 PM Krsnaa Diagnostics - Quaterly Results 6 Feb, 12:00 AM Krsnaa Diagnostics informs about compliances-certificate 6 Jan, 4:25 PM Krsnaa Diagnostics informs about closure of trading window 26 Dec, 5:27 PM Krsnaa Diagnostics informs about analyst meet 26 Nov, 11:18 AM Krsnaa Diagnostics informs about certificate 3 Oct, 4:36 PM Krsnaa Diagnostics informs about analyst meet 10 Sep, 2:51 PM Krsnaa Diagnostics informs about newspaper advertisement 13 Aug, 12:03 PM Krsnaa Diagnostics - Quaterly Results 11 Aug, 7:15 PM Krsnaa Diagnostics - Quaterly Results 11 Aug, 7:15 PM Krsnaa Diagnostics informs about analyst meet 26 Jun, 12:37 PM Krsnaa Diagnostics - Quaterly Results 12 May, 7:20 PM Krsnaa Diagnostics - Quaterly Results 12 May, 7:20 PM Krsnaa Diagnostics informs about analyst meet 22 Mar, 3:11 PM Krsnaa Diagnostics informs about press release 12 Mar, 3:15 PM Krsnaa Diagnostics informs about notice of postal ballot 11 Mar, 5:02 PM Krsnaa Diagnostics informs about earnings call transcript 20 Feb, 6:21 PM Krsnaa Diagnostics informs about press release 14 Feb, 2:45 PM Krsnaa Diagnostics informs about outcome of board meeting 12 Feb, 5:25 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 3:18 PM Krsnaa Diagnostics informs about analyst meet 15 Jan, 1:09 PM Krsnaa Diagnostics informs about analyst meet 6 Jan, 3:41 PM Krsnaa Diagnostics informs about disclosure 3 Jan, 5:22 PM Krsnaa Diagnostics informs about analyst meet 1 Jan, 2:43 PM Krsnaa Diagnostics informs about trading window closure 23 Dec, 12:26 PM Krsnaa Diagnostics informs about analyst meet 6 Nov, 12:52 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics to expand Radiology services, Pathology laboratory services in Ranchi 11 Oct, 10:22 AM Krsnaa Diagnostics informs about analyst meet 8 Oct, 4:56 PM Krsnaa Diagnostics enters into strategic partnership with Medikabazaar 1 Oct, 2:40 PM Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare 26 Sep, 4:51 PM Krsnaa Diagnostics submits analyst meet intimation 27 Aug, 12:44 PM Krsnaa Diagnostics informs about newspaper publication 24 Aug, 2:46 PM Krsnaa Diagnostics informs about newspaper publication 8 Aug, 1:14 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics gets tender from Bhabha Atomic Research Centre 5 Jul, 10:58 AM Krsnaa Diagnostics informs about closure of trading window 22 Jun, 3:53 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics inks pact with Government of Maharashtra 2 May, 3:29 PM Krsnaa Diagnostics incorporates wholly owned subsidiary 9 Apr, 3:26 PM

Krsnaa Diagnostics Stock Price Analysis and Quick Research Report. Is Krsnaa Diagnostics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Krsnaa Diagnostics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Krsnaa Diagnostics has a PE ratio of 23.7220605272825 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Krsnaa Diagnostics has ROA of 6.7464% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Krsnaa Diagnostics has a Current ratio of 1.4008.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Krsnaa Diagnostics has a ROE of 9.7438%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Krsnaa Diagnostics has a Debt to Equity ratio of 0.2273 which means that the company has low proportion of debt in its capital.

  • Sales growth: Krsnaa Diagnostics has reported revenue growth of 15.5378% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Krsnaa Diagnostics for the current financial year is 28.8482385817704%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Krsnaa Diagnostics is Rs 2.75 and the yield is 0.4659%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Krsnaa Diagnostics is Rs 24.7723. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Krsnaa Diagnostics in Ticker for free. Also, one can get the intrinsic value of Krsnaa Diagnostics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Krsnaa Diagnostics FAQs

Q1. What is Krsnaa Diagnostics share price today?
Ans: The current share price of Krsnaa Diagnostics is Rs 587.65.

Q2. What is the market capitalisation of Krsnaa Diagnostics?
Ans: Krsnaa Diagnostics has a market capitalisation of Rs 1906.25856008 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Krsnaa Diagnostics?
Ans: The PE ratio of Krsnaa Diagnostics is 23.7220605272825 and the P/B ratio of Krsnaa Diagnostics is 2.01025636113666, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Krsnaa Diagnostics share?
Ans: The 52-week high share price of Krsnaa Diagnostics is Rs 894.4, and the 52-week low share price of Krsnaa Diagnostics is Rs 579.15.

Q5. Does Krsnaa Diagnostics pay dividends?
Ans: Currently, Krsnaa Diagnostics pays dividends. Dividend yield of Krsnaa Diagnostics is around 0.4659%.

Q6. What are the face value and book value of Krsnaa Diagnostics shares?
Ans: The face value of Krsnaa Diagnostics shares is Rs 5, while the book value per share of Krsnaa Diagnostics is around Rs 292.3259. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Krsnaa Diagnostics?
Ans: Krsnaa Diagnostics has a total debt of Rs 201.617 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Krsnaa Diagnostics?
Ans: The ROE of Krsnaa Diagnostics is 9.7438% and ROCE of Krsnaa Diagnostics is 12.9634%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Krsnaa Diagnostics a good buy for the long term?
Ans: The Krsnaa Diagnostics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Krsnaa Diagnostics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Krsnaa Diagnostics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Krsnaa Diagnostics’s financials?
Ans: You can review Krsnaa Diagnostics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Krsnaa Diagnostics Share Price News

Latest updates on Krsnaa Diagnostics share price and stock news.

Last Updated on:
Brief about Krsnaa Diagnostics
X